RYMMX
Price
$60.09
Change
-$0.76 (-1.25%)
Updated
Nov 13 closing price
Net Assets
5.31M
VISVX
Price
$49.42
Change
-$0.68 (-1.36%)
Updated
Nov 13 closing price
Net Assets
58.35B
Interact to see
Advertisement

RYMMX vs VISVX

Header iconRYMMX vs VISVX Comparison
Open Charts RYMMX vs VISVXBanner chart's image
Rydex S&P MidCap 400 Pure Value C
Price$60.09
Change-$0.76 (-1.25%)
VolumeN/A
Net Assets5.31M
Vanguard Small Cap Value Index I
Price$49.42
Change-$0.68 (-1.36%)
VolumeN/A
Net Assets58.35B
RYMMX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
RYMMX vs. VISVX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYMMX is a Hold and VISVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 58.3B vs. RYMMX (5.31M). VISVX pays higher dividends than RYMMX: VISVX (1.90) vs RYMMX (0.00). RYMMX was incepted earlier than VISVX: RYMMX (22 years) vs VISVX (28 years). RYMMX (2.34) is less costly to investors than VISVX (0.19). RYMMX is a more actively managed with annual turnover of: 3996.00 vs. VISVX (16.00). RYMMX has a lower initial minimum investment than VISVX: RYMMX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : -0.55 vs. RYMMX (-6.25). VISVX return over 5 years is better than : 65.01 vs. RYMMX (41.65).
RYMMXVISVXRYMMX / VISVX
Total Expense Ratio2.290.191,205%
Annual Report Gross Expense Ratio2.340.191,232%
Fund Existence22 years28 years-
Gain YTD4.4465.77177%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.31M58.3B0%
Annual Yield % from dividends0.001.90-
Returns for 1 year-6.25-0.551,133%
Returns for 3 years2.9027.3111%
Returns for 5 years41.6565.0164%
Returns for 10 years65.42116.5956%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.660.04
+1.53%
Spero Therapeutics
MRKR0.940.01
+1.28%
Marker Therapeutics
PHG29.380.05
+0.17%
Koninklijke Philips NV
RYN22.14-0.24
-1.07%
Rayonier
NOAH11.21-0.13
-1.15%
Noah Holdings Limited